ASSA ABLOY UNSP ADR EA REP 0.5 ORD SHS (ASAZY) EPS Estimated At $0.12; Leavell Investment Management Has Increased By $350,020 Its Amgen Com (AMGN) Stake

October 13, 2017 - By Louis Casey

Analysts expect ASSA ABLOY UNSP ADR EA REP 0.5 ORD SHS (OTCMKTS:ASAZY) to report $0.12 EPS on October, 20.They anticipate $0.01 EPS change or 9.09% from last quarter’s $0.11 EPS. ASAZY’s profit would be $254.00 million giving it 22.85 P/E if the $0.12 EPS is correct. After having $0.11 EPS previously, ASSA ABLOY UNSP ADR EA REP 0.5 ORD SHS’s analysts see 9.09% EPS growth. The stock decreased 0.29% or $0.03 during the last trading session, reaching $10.97. About 77,648 shares traded. ASSA ABLOY UNSP ADR EA REP 0.5 ORD SHS (OTCMKTS:ASAZY) has 0.00% since October 13, 2016 and is . It has underperformed by 16.70% the S&P500.

Leavell Investment Management Inc increased Amgen Inc Com (AMGN) stake by 17.9% reported in 2017Q2 SEC filing. Leavell Investment Management Inc acquired 2,035 shares as Amgen Inc Com (AMGN)’s stock declined 9.68%. The Leavell Investment Management Inc holds 13,406 shares with $2.31 million value, up from 11,371 last quarter. Amgen Inc Com now has $133.36 billion valuation. The stock decreased 0.75% or $1.39 during the last trading session, reaching $182.76. About shares traded. Amgen, Inc. (NASDAQ:AMGN) has risen 5.27% since October 13, 2016 and is uptrending. It has underperformed by 11.43% the S&P500.

Leavell Investment Management Inc decreased Spdr Sr Trbrclys S/T Muni Etf stake by 20,253 shares to 26,870 valued at $1.30M in 2017Q2. It also reduced Vanguard Index Fds S&P 500 Etf (VOO) stake by 1,610 shares and now owns 26,548 shares. Chevron Corp New Com (NYSE:CVX) was reduced too.

Since May 24, 2017, it had 0 insider purchases, and 2 selling transactions for $1.02 million activity. On Wednesday, May 24 Patton Cynthia M sold $451,164 worth of Amgen, Inc. (NASDAQ:AMGN) or 2,922 shares. 3,700 shares were sold by BALTIMORE DAVID, worth $569,541.

Among 22 analysts covering Amgen Inc. (NASDAQ:AMGN), 11 have Buy rating, 0 Sell and 11 Hold. Therefore 50% are positive. Amgen Inc. has $218 highest and $160 lowest target. $190.75’s average target is 4.37% above currents $182.76 stock price. Amgen Inc. had 64 analyst reports since August 3, 2015 according to SRatingsIntel. On Tuesday, December 20 the stock rating was downgraded by Credit Suisse to “Neutral”. Vetr upgraded the shares of AMGN in report on Friday, August 21 to “Buy” rating. The rating was maintained by Oppenheimer with “Buy” on Friday, July 28. The firm has “Buy” rating by BMO Capital Markets given on Friday, July 21. Argus Research maintained it with “Buy” rating and $185 target in Monday, February 8 report. The rating was maintained by RBC Capital Markets on Friday, July 31 with “Outperform”. Jefferies downgraded Amgen, Inc. (NASDAQ:AMGN) on Wednesday, April 5 to “Hold” rating. The stock of Amgen, Inc. (NASDAQ:AMGN) has “Neutral” rating given on Thursday, February 25 by Citigroup. The firm has “Outperform” rating by Oppenheimer given on Tuesday, December 13. Jefferies maintained the shares of AMGN in report on Monday, June 12 with “Hold” rating.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Twitter Auto Publish Powered By : XYZScripts.com